company background image
ATB

Antibiotice BVB:ATB Stock Report

Last Price

RON0.54

Market Cap

RON359.8m

7D

3.9%

1Y

-9.8%

Updated

05 Dec, 2022

Data

Company Financials
ATB fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends0/6

ATB Stock Overview

Antibiotice S.A. produces and sells medicinal products in Romania.

Antibiotice S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Antibiotice
Historical stock prices
Current Share PriceRON0.54
52 Week HighRON0.61
52 Week LowRON0.48
Beta0.13
1 Month Change7.20%
3 Month Change2.68%
1 Year Change-9.76%
3 Year Change7.20%
5 Year Change-2.19%
Change since IPO550.58%

Recent News & Updates

Is Antibiotice (BVB:ATB) A Risky Investment?

Jun 08
Is Antibiotice (BVB:ATB) A Risky Investment?

Recent updates

Is Antibiotice (BVB:ATB) A Risky Investment?

Jun 08
Is Antibiotice (BVB:ATB) A Risky Investment?

These 4 Measures Indicate That Antibiotice (BVB:ATB) Is Using Debt Extensively

Mar 10
These 4 Measures Indicate That Antibiotice (BVB:ATB) Is Using Debt Extensively

Tread With Caution Around Antibiotice S.A.'s (BVB:ATB) 5.8% Dividend Yield

Feb 11
Tread With Caution Around Antibiotice S.A.'s (BVB:ATB) 5.8% Dividend Yield

Calculating The Intrinsic Value Of Antibiotice S.A. (BVB:ATB)

Jan 12
Calculating The Intrinsic Value Of Antibiotice S.A. (BVB:ATB)

Are Antibiotice's (BVB:ATB) Statutory Earnings A Good Guide To Its Underlying Profitability?

Dec 16
Are Antibiotice's (BVB:ATB) Statutory Earnings A Good Guide To Its Underlying Profitability?

Is Antibiotice (BVB:ATB) Using Too Much Debt?

Nov 24
Is Antibiotice (BVB:ATB) Using Too Much Debt?

Shareholder Returns

ATBRO PharmaceuticalsRO Market
7D3.9%1.4%1.7%
1Y-9.8%3.7%-4.3%

Return vs Industry: ATB underperformed the RO Pharmaceuticals industry which returned 3.7% over the past year.

Return vs Market: ATB underperformed the RO Market which returned -4.3% over the past year.

Price Volatility

Is ATB's price volatile compared to industry and market?
ATB volatility
ATB Average Weekly Movement2.7%
Pharmaceuticals Industry Average Movement5.3%
Market Average Movement4.2%
10% most volatile stocks in RO Market9.2%
10% least volatile stocks in RO Market2.7%

Stable Share Price: ATB is less volatile than 75% of RO stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: ATB's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19551,361Ioan Nanihttps://www.antibiotice.ro

Antibiotice S.A. produces and sells medicinal products in Romania. The company’s portfolio of products comprises approximately 157 medicines for a range of therapeutic areas, such as cardiovascular system, alimentary tract and metabolism, musculo-skeletal system, nervous system, antiinfectives, respiratory system, dermatological, food supplements, sensory organs, genito-urinary apparatus and sexual hormones, varia, and blood and blood forming organs, as well as veterinary medicinal products. It offers its products in the form of sterile injectable powders, capsules, tablets, ointments, gels, creams, and suppositories.

Antibiotice S.A. Fundamentals Summary

How do Antibiotice's earnings and revenue compare to its market cap?
ATB fundamental statistics
Market CapRON359.84m
Earnings (TTM)RON41.20m
Revenue (TTM)RON495.67m

8.7x

P/E Ratio

0.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ATB income statement (TTM)
RevenueRON495.67m
Cost of RevenueRON170.13m
Gross ProfitRON325.54m
Other ExpensesRON284.34m
EarningsRON41.20m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.061
Gross Margin65.68%
Net Profit Margin8.31%
Debt/Equity Ratio13.3%

How did ATB perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

5%

Payout Ratio